The National Institutes of Health (NIH) is offering this R61/R33 grant to support projects focused on developing or utilizing advanced in situ or in vivo imaging and related technologies. This grant is specifically designed to investigate crucial HIV/SIV-relevant processes, encompassing infection, latent reservoirs, and the pathogenic consequences of HIV/SIV, particularly within the context of Substance Use Disorders (SUDs). Researchers may also explore the effects of HIV/SIV or SUD therapies. Applicants are encouraged to propose studies involving primate or human subjects, with a focus on tissues like blood, lymphoid organs, and the brain, aiming to deepen our understanding of these complex conditions.
Opportunity ID: 334642
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-23-001 |
Funding Opportunity Title: | Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jul 09, 2021 |
Last Updated Date: | Jul 09, 2021 |
Original Closing Date for Applications: | Aug 11, 2022 |
Current Closing Date for Applications: | Aug 11, 2022 |
Archive Date: | Sep 16, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public housing authorities/Indian housing authorities State governments City or township governments Public and State controlled institutions of higher education Independent school districts Small businesses Special district governments County governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this initiative is to support projects that further develop or exploit advances using in situ or in vivo imaging or related technologies to investigate HIV/SIV infection, latent reservoirs, the pathogenic consequences of HIV/SIV infection, or the effects of HIV/SIV or substance use disorder (SUD) therapies. Applicants may propose primate or human studies to investigate blood, lymphoid, or brain tissues. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-001.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 334642 Full Announcement-RFA-DA-23-001 -> RFA-DA-23-001-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270620 | Jul 11, 2022 | Aug 11, 2022 | View | |
FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268153 | Aug 16, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334642 RR_SF424_5_0-5.0.pdf
334642 PHS398_CoverPageSupplement_5_0-5.0.pdf
334642 RR_OtherProjectInfo_1_4-1.4.pdf
334642 PerformanceSite_4_0-4.0.pdf
334642 RR_KeyPersonExpanded_4_0-4.0.pdf
334642 RR_Budget_3_0-3.0.pdf
334642 PHS398_ResearchPlan_4_0-4.0.pdf
334642 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334642 RR_SubawardBudget30_3_0-3.0.pdf
334642 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334642 RR_SF424_2_0-2.0.pdf
334642 PHS398_CoverPageSupplement_5_0-5.0.pdf
334642 RR_OtherProjectInfo_1_4-1.4.pdf
334642 PerformanceSite_2_0-2.0.pdf
334642 RR_KeyPersonExpanded_2_0-2.0.pdf
334642 RR_Budget_1_4-1.4.pdf
334642 PHS398_ResearchPlan_4_0-4.0.pdf
334642 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334642 RR_SubawardBudget30_1_4-1.4.pdf
334642 PHS_AssignmentRequestForm_3_0-3.0.pdf